RxDoctor Payments Data

Rommel Rivera, MD

Psychiatry · Philadelphia, PANPI 1619098159

Payments from drug & device makers

$11,931in general payments, 2019–2025

Across 48 payments — averaging $248.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Otsuka America Pharmaceutical, Inc.$11K
  • AbbVie$141
  • Tactile Systems Technology Inc$80
  • Johnson & Johnson$72
  • Alkermes, Inc.$69
  • Teva Pharmaceuticals USA, Inc.$54
  • plus $39 from 1 others

What the payments were for

  • Speaking & faculty fees$9,82082%
  • Travel & lodging$1,1109%
  • Food & beverage$9228%
  • Education$801%

General payments by program year

19
20
21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,931 in reported general payments places this provider in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.

See all psychiatry providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$47,156
Medicare patients
50
Services billed
489

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl19$43,998
Divalproex Sodium ErDivalproex Sodium79$3,392
Venlafaxine Hcl ErVenlafaxine Hcl117$2,730
Duloxetine Hcl55$2,410
Bupropion XlBupropion Hcl83$2,010
Olanzapine49$1,597
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine13$1,007
Trazodone Hcl103$927
Mirtazapine48$740
Aripiprazole36$717
Escitalopram Oxalate50$667
Sertraline Hcl78$650
Quetiapine Fumarate77$619
Buspirone Hcl39$611
Alprazolam61$550

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$141$43,99819 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,838 psychiatry providers in Pennsylvania.

Other psychiatry in Philadelphia

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →